Skip navigation
Use este identificador para citar ou linkar para este item: http://repositorio.unb.br/handle/10482/44690
Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
ARTIGO_EffectsInVitro.pdf736,69 kBAdobe PDFVisualizar/Abrir
Registro completo de metadados
Campo DCValorIdioma
dc.contributor.authorMota, Tales Henrique Andrade da-
dc.contributor.authorGuimarães, Ana Flavia Reis-
dc.contributor.authorCarvalho, Amandda Évelin Silva de-
dc.contributor.authorAraújo, Felipe Saldanha de-
dc.contributor.authorLopes, Giselle Pinto de Faria-
dc.contributor.authorPittella-Silva, Fabio-
dc.contributor.authorRabello, Doralina do Amaral-
dc.contributor.authorOliveira, Diego Madureira de-
dc.date.accessioned2022-09-05T13:07:20Z-
dc.date.available2022-09-05T13:07:20Z-
dc.date.issued2021-
dc.identifier.citationMOTA, Tales Henrique Andrade da et al. Effects of in vitro short- and long-term treatment with telomerase inhibitor in U-251 glioma cells. Tumor Biology, v. 43, p. 327-340, 2021. DOI: 10.3233/TUB-211515. Disponível em: https://content.iospress.com/articles/tumor-biology/tub211515. Acesso em:05 set. 2022.pt_BR
dc.identifier.urihttps://repositorio.unb.br/handle/10482/44690-
dc.language.isoInglêspt_BR
dc.publisherIOS Presspt_BR
dc.rightsAcesso Abertopt_BR
dc.titleEffects of in vitro short- and long-term treatment with telomerase inhibitor in U-251 glioma cellspt_BR
dc.typeArtigopt_BR
dc.subject.keywordGliomapt_BR
dc.subject.keywordTelomerasept_BR
dc.subject.keywordCâncer - tratamentopt_BR
dc.rights.license© 2021 – The authors. Published by IOS Press. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC 4.0)pt_BR
dc.identifier.doi10.3233/TUB-211515pt_BR
dc.description.abstract1BACKGROUND: The inhibition of the enzyme telomerase (TERT) has been widely investigated as a new pharmacological approach for cancer treatment, but its real potential and the biochemical consequences are not totally understood. OBJECTIVE: Here, we investigated the effects of the telomerase inhibitor MST-312 on a human glioma cell line after both short- and long-term (290 days) treatments. METHODS: Effects on cell growth, viability, cell cycle, morphology, cell death and genes expression were assessed. RESULTS: We found that short-term treatment promoted cell cycle arrest followed by apoptosis. Importantly, cells with telomerase knock-down revealed that the toxic effects of MST-312 are partially TERT dependent. In contrast, although the long-term treatment decreased cell proliferation at first, it also caused adaptations potentially related to treatment resistance and tumor aggressiveness after long time of exposition. CONCLUSIONS: Despite the short-term effects of telomerase inhibition not being due to telomere erosion, they are at least partially related to the enzyme inhibition, which may represent an important strategy to pave the way for tumor growth control, especially through modulation of the non-canonical functions of telomerase. On the other hand, long-term exposure to the inhibitor had the potential to induce cell adaptations with possible negative clinical implications.pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-6272-6558pt_BR
dc.contributor.affiliationUniversidade de Brasília, Faculdade UnB Ceilândiapt_BR
dc.contributor.affiliationUniversidade de Brasília, Faculdade de Ciências da Saúde, Departamento de Farmáciapt_BR
dc.contributor.affiliationUniversidade de Brasília, Faculdade de Ciências da Saúde, Departamento de Farmáciapt_BR
dc.contributor.affiliationUniversidade de Brasília, Faculdade de Ciências da Saúde, Departamento de Farmáciapt_BR
dc.contributor.affiliationLaboratório de Hemato-oncologia Celular e Molecular, Instituto Nacional do Câncer (INCA)pt_BR
dc.contributor.affiliationDepartamento de Biotecnologia Marinha, Instituto de Estudos do Mar do Almirante Paulo Moreira, IEAPMpt_BR
Aparece nas coleções:Artigos publicados em periódicos e afins

Mostrar registro simples do item Visualizar estatísticas



Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.